Multi-Stability and Multi-Instability Phenomena in a Mathematical Model of Tumor-Immune-Virus Interactions

Bulletin of Mathematical Biology

Volumn 73, Issue 12, 2011, Pages 2932-2961

  Eftimie, Raluca ^a   Dushoff, Jonathan ^a,c   Bridle, Byram W ^b   Bramson, Jonathan L ^b,c   Earn, David J D ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Cancer immunology; Mathematical model; Multi instability; Multi stability; Oncolytic virus

Indexed keywords

CANCER VACCINE; TUMOR ANTIGEN; VIRUS VACCINE;

ARTICLE; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MATHEMATICAL PHENOMENA; NEOPLASM; NONLINEAR SYSTEM; ONCOLYTIC VIROTHERAPY; VIROLOGY;

ANTIGENS, NEOPLASM; CANCER VACCINES; HUMANS; IMMUNOLOGIC MEMORY; MATHEMATICAL CONCEPTS; MODELS, BIOLOGICAL; NEOPLASMS; NONLINEAR DYNAMICS; ONCOLYTIC VIROTHERAPY; VIRAL VACCINES;

EID: 80855143747     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-011-9653-5     Document Type: Article

References (63)

1. Alemany, R., Suzuki, K., & Curiel, D. T. (2000). Blood clearance rates of adenovirus type 5 in mice. J. Gen. Virol., 81, 2605-2609.
2. Angeli, D., Ferrell, J. E., & Sontag, E. D. (2004). Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems. Proc. Natl. Acad. Sci. USA, 101(7), 1822-1827.
3. Araujo, R. P., & McElwain, D. L. S. (2004). A history of the stdy of solid tumor growth: the contribution of mathematical modeling. Bull. Math. Biol., 66, 1039-1091.
4. + T cell homeostasis by perforin and Interferon-γ. Science, 290(5495), 1354-1357.
5. Bahl, K., Kim, S.-K., Calcagno, C., Ghersi, D., Puzone, R., Celada, F., Selin, L. K., & Welsh, R. M. (2006). IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infection. J. Immunol., 176, 4284-4295.
6. Bajzer, Z., Carr, T., Josić, K., Russell, S. J., & Dingli, D. (2008). Modeling of cancer virotherapy with recombinant measles viruses. J. Theor. Biol., 252, 109-122.
7. Biesecker, M., Kimn, J.-H., Lu, H., Dingli, D., & Bajzer, Z. (2010). Optimization of virotherapy for cancer. Bull. Math. Biol., 72, 469-489.
8. Billings, L., & Schwartz, I. B. (2002). Exciting chaos with noise: unexpected dynamics in epidemic outbreaks. J. Math. Biol., 44(1), 31-48.
9. Blohm, U., Potthoff, D., van der Kogel, A. J., & Pircher, H. (2006). Solid tumors "melt" from the inside after successful CD8 T cell attack. Eur. J. Immunol., 36(2), 468-477.
10. Bluming, A. Z., & Ziegler, J. L. (1971). Regression of Burkitt's lymphoma in association with measles infection. Lancet, 2(7715), 105-106.
11. Breitbach, C. J., Paterson, J. M., Lemay, C. G., Falls, T. J., McGuire, A., Parato, K. A., Stojdl, D. F., Daneshmand, M., Speth, K., Kirn, D., McCart, J. A., Atkins, H., & Bell, J. C. (2007). Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow. Molec. Ther., 15(9), 1686-1693.
12. Bridle, B. W., Boudreau, J. E., Lichty, B. D., Brunellière, J., Stephenson, K., Koshy, S., Bramson, J. L., & Wan, Y. (2009). Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus. Molec. Ther., 17(10), 1814-1821.
13. Bridle, B. W., Stephenson, K. B., Boudreau, J. E., Koshy, S., Kazdhan, N., Pullenayegum, E., Brunellière, J., Bramson, J. L., Lichty, B. D., & Wan, Y. (2010). Potentiating cancer immunotherapy using an oncolytic virus. Molec. Ther., 18(8), 1430-1439.
14. 32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice. J. Immunol., 85, 99-105.
15. Buhl, J., Sumpter, D. J. T., Couzin, I. D., Hale, J. J., Despland, E., Miller, E. R., & Simpson, S. J. (2006). From disorder to order in marching locusts. Science, 312(5778), 1402-1406.
16. Bunimovich-Mendrazitsky, S., Shochat, E., & Stone, L. (2007). Mathematical model of BCG immunotherapy in superficial bladder cancer. Bull. Math. Biol., 69, 1847-1870.
17. Byrne, H. M., Cox, S. M., & Kelly, C. E. (2004). Macrophage-tumor interactions: In vivo dynamics. Discrete Contin. Dyn. Syst., Ser. B, 4(1), 81-98.
18. Canabarro, A. A., Gléria, I. M., & Lyra, M. L. (2004). Periodic solutions and chaos in a non-linear model for the delayed cellular immune response. Physica A, 342, 234-241.
19. Cappuccio, A., Castiglione, F., & Piccoli, B. (2007). Determination of the optimal therapeutic protocols in cancer immunotherapy. Math. Biosci., 209(1), 1-13.
20. Chang, H. H., Oh, P. Y., Ingber, D. E., & Huang, S. (2006). Multistable and multistep dynamics in neutrophil differentiation. BMC Cell Biol., 7, 11.
21. Choi, B. K., Kim, Y. H., Kan, W. J., Lee, S. K., Kim, K. H., Shin, S. M., Yokoyama, W. M., Kim, T. Y., & Kwon, B. S. (2007). Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy. Cancer Res., 67(18), 8891-8899.
22. Choisy, M., Guégan, J.-F., & Rohani, P. (2006). Dynamics of infectious diseases and pulse vaccination: teasing apart the embedded resonance effects. Physica D, 223, 26-35.
23. Cooper, D., Wright, K. J., Calderon, P. C., Guo, M., Nasar, F., Johnson, J. E., Coleman, J. W., Lee, M., Kotash, C., Yurgelonis, I., Natuk, R. J., Hendry, R. M., Udem, S. A., & Clarke, D. K. (2008). Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocation and G gene truncation reduces neurovirulence and enhances immunogenicity in mice. J. Virol., 82(1), 207-219.
24. Curran, M. A., Montalvo, W., Yagita, H., & Allison, J. P. (2010). PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc. Natl. Acad. Sci. USA, 107(9), 4275-4280.
25. + T-cell response to lymphocytic choriomeningitis virus. J. Virol., 75(22), 10663-10669.
26. Diaz, R. M., Galivo, F., Kottke, T., Wongthida, P., Qiao, J., Thompson, J., Valdes, M., Barber, G., & Vile, R. G. (2007). Oncolytic immunotherapy for melanoma using vesicular stomatitis virus. Cancer Res., 67(6), 2840-2848.
27. Dingli, D., Offord, C., Myers, R., Peng, K.-W., Carr, T. W., Josic, K., Russell, S. J., & Bajzer, Z. (2009). Dynamics of multiple myeloma tumor therapy with a recombinant measles virus. Cancer Gene Ther., 16(12), 873-882.
28. Dock, G. (1904). Rabies virus vaccination in a patient with cervical carcinoma. Am. J. Med. Sci., 127, 563.
29. Earn, D. J. D., Rohani, P., Bolker, B. M., & Grenfell, B. T. (2000). A simple model for complex dynamical transitions in epidemics. Science, 287(5453), 667-670.
30. Eftimie, R., Bramson, J. L., & Earn, D. J. D. (2010). Interactions between the immune system and cancer: a brief review of non-spatial mathematical models. Bull. Math. Biol., 73(1), 2-32.
31. Egan, M. A., Chong, S. Y., Rose, N. F., Megati, S., Lopez, K. J., Schadeck, E. B., Johnson, J. E., Masood, A., Piacente, P., Duilhet, R. E., Barras, P. W., Hasselschwert, D. L., Reilly, P., Mishkin, E. M., Montefiori, D. C., Lewis, M. G., Clarke, D. K., Hendrix, R. M., Marx, P. A., Eldridge, J. H., Udem, S. A., Israel, Z. R., & Rose, J. K. (2004). Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes. AIDS Res. Hum. Retrovir. B, 20(9), 989-1004.
32. Eißing, T., Conzelmann, H., Gilles, E., Allgöwer, F., Bullinger, E., & Scheurich, P. (2004). Bistability analysis of a caspase activation model for receptor-induced apoptosis. J. Biol. Chem., 279, 36892-36897.
33. Ferreira, S. C., Martins, M. L., & Vilela, M. J. (2005). Fighting cancers with viruses. Physica A, 345(3-4), 591-602.
34. Fiasconaro, A., Ochab-Marcinek, A., Spagnolo, B., & Gudowska-Nowak, E. (2008). Monitoring noise-resonant effects in cancer growth influenced by external fluctuations and periodic treatment. Eur. Phys. J. B, 65, 435-442.
35. + T-cell expansion and maintenance following immunization with recombinant adenovirus. J. Virol., 83(23), 12027-12036.
36. Friedman, A., Tian, J. P., Fulci, G., Chiocca, E. A., & Wang, J. (2006). Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity. Cancer Res., 66(4), 2314-2319.
37. Hansen, R. M., & Libnoch, J. A. (1978). Remission of chronic lymphocytic leukemia after smallpox vaccination. Arch. Intern. Med., 138, 1137-1138.
38. Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002). Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol., 2, 251-262.
39. Kirschner, D., & Panetta, J. C. (1998). Modeling immunotherapy of the tumor-immune interaction. J. Math. Biol., 37, 235-252.
40. Kündig, T. M., Bachmann, M. F., Oehen, S., Hoffmann, U. W., Simard, J. J. L., Kalberer, C. P., Pircher, H., Ohashi, P. S., Hengartner, H., & Zinkernagel, R. F. (1996). On the role of antigen maintaining cytotoxic T-cell memory. Proc. Natl. Acad. Sci. USA, 93, 9716-9723.
41. Lefever, R., & Horsthemke, W. (1979). Bistability in fluctuating environments. Implications in tumor immunology. Bull. Math. Biol., 41, 469-490.
42. Lejeune, O., Chaplain, M. A. J., & El Akili, I. (2008). Oscillations and bistability in the dynamics of cytotoxic reactions mediated by the response of immune cells to solid tumors. Math. Comput. Model., 47, 649-662.
43. Lord, C. C., & Tabachnick, W. J. (2002). Influence of nonsystemic transmission on the epidemiology of insect borne arboviruses: a case study of vesicular stomatitis epidemiology in the Western United States. J. Med. Entomol., 39(3), 417-426.
44. Marsden, V. S., Kappler, J. W., & Marrack, P. C. (2006). Homeostasis of the memory T cell pool. Int. Arch. Allergy Immunol., 139, 63-74.
45. Mullen, J. T., & Tanabe, K. K. (2002). Viral oncolysis. Oncologist, 7, 106-119.
46. Munks, M. W., Mourich, D. V., Mittler, R. S., Weinberg, A. D., & Hill, A. B. (2004). 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine. Immunology, 112, 559-566.
47. Nowak, M., & May, R. (2000). Virus dynamics: mathematical principles of immunology and virology. London: Oxford University Press.
48. Paiva, L. R., Binny, C., Ferreira, S. C. Jr., & Martins, M. L. (2009). A multiscale mathematical model for oncolytic virotherapy. Cancer Res., 69(3), 1205-1211.
49. Perko, L. (2000). Differential equations and dynamical systems. New York: Springer.
50. Pomerening, J. R. (2008). Uncovering mechanisms of bistability in biological systems. Curr. Opin. Biotechnol., 19(4), 381-388.
51. Reth, M., & Brummer, T. (2004). Feedback regulation of lymphocyte signaling. Nat. Rev. Immunol., 4, 269-277.
52. Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004). Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol., 22, 745-763.
53. Schattner, A., Meshorer, A., & Wallach, D. (1983). Involvement of interferon in virus-induced lymphopenia. Cell. Immunol., 79, 11-25.
54. Schwartz, I. B., & Carr, T. W. (1999). Bi-instability as a precursor to global mixed-mode chaos. Phys. Rev. E, 59(6), 6658-6661.
55. Schwartz, I. B., & Smith, H. L. (1983). Infinite subharmonic bifurcation in an SEIR model. J. Math. Biol., 18, 233-253.
56. Silva, N. D., Atkins, H., Kirn, D. H., Bell, J. C., & Breitbach, C. J. (2010). Double trouble for tumours: Exploiting the tumour microenvironment to enhance anticancer effect of oncolytic viruses. Cytokine Growth Factor Rev., 21(2-3), 135-141.
57. Thompson, J. M. T., Stewart, H. B., & Ueda, Y. (1994). Safe, explosive, and dangerous bifurcations in dissipative dynamical systems. Phys. Rev. E, 49, 1019-1027.
58. Turner, D. L., Cauley, L. S., Khanna, K. M., & Lefrançois, L. (2007). Persistent antigen presentation after acute vesicular stomatitis virus infection. J. Virol., 81(4), 2039-2046.
59. Wein, L. M., Wu, J. T., & Kirn, D. H. (2003). Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res., 63, 1317-1324.
60. Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003). Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol., 4(3), 225-234.
61. Wodarz, D. (2001). Viruses as antitumor weapons: defining conditions for tumor remission. Cancer Res., 61, 3501-3507.
62. Wodarz, D., & Komarova, N. (2009). Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection. PLoS ONE, 4(1), e4271.
63. Wu, J. T., Kirn, D. H., & Wein, L. M. (2004). Analysis of a three-way race between tumor growth, a replication-competent virus and an immune response. Bull. Math. Biol., 66(4), 605-625.